Literature DB >> 11584809

Silica sol-gel for the controlled release of antibiotics. II. The effect of synthesis parameters on the in vitro release kinetics of vanomycin.

W Aughenbaugh1, S Radin, P Ducheyne.   

Abstract

Room temperature-processed silica sol-gel (xerogel) was investigated as a novel controlled release carrier of vancomycin for the treatment of osteomyelitis. Vancomycin-loaded xerogels were fabricated with varying water/alkoxysilane molar ratios and vancomycin concentrations. The goal of this study was to determine the effect of varying the aforementioned synthesis parameters on the daily in vitro release kinetics of vancomycin from the xerogel disks. A controlled, load-dependent, long-term release of vancomycin was observed for all of the molar ratios that were used in the study (4, 6, and 10). Variations in the water/alkoxysilane molar ratio affected the release process extensively. A cumulative release of about 90% of the original amount of vancomycin was found for molar ratios 6 and 10 by 21 and 14 days, respectively. Only about 30% was released from xerogels with a molar ratio of 4 after 21 days of immersion. A first-order release stage was followed by a steady release stage for xerogels with molar ratios of 6 and 10, whereas zero-order release was observed for xerogels with a molar ratio of 4. The findings of this study indicate that the release kinetics of vancomycin from xerogel can be tailored by varying the xerogel synthesis parameters.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11584809     DOI: 10.1002/1097-4636(20011205)57:3<321::aid-jbm1174>3.0.co;2-s

Source DB:  PubMed          Journal:  J Biomed Mater Res        ISSN: 0021-9304


  6 in total

1.  Stimulated osteoblastic proliferation by mesoporous silica xerogel with high specific surface area.

Authors:  Huanjun Zhou; Xiaohui Wu; Jie Wei; Xun Lu; Shuo Zhang; Jianlin Shi; Changsheng Liu
Journal:  J Mater Sci Mater Med       Date:  2011-02-02       Impact factor: 3.896

Review 2.  Nanostructured platforms for the sustained and local delivery of antibiotics in the treatment of osteomyelitis.

Authors:  Vuk Uskokovic
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2015       Impact factor: 4.889

3.  Controlled release of small molecules from silica xerogel with limited nanoporosity.

Authors:  Rong Chen; Haibo Qu; Ashwin Agrawal; Shaoyun Guo; Paul Ducheyne
Journal:  J Mater Sci Mater Med       Date:  2012-10-10       Impact factor: 3.896

4.  Silica xerogel-chitosan nano-hybrids for use as drug eluting bone replacement.

Authors:  Eun-Jung Lee; Shin-Hee Jun; Hyoun-Ee Kim; Hae-Won Kim; Young-Hag Koh; Jun-Hyeog Jang
Journal:  J Mater Sci Mater Med       Date:  2009-08-06       Impact factor: 3.896

5.  Silica-Gentamicin Nanohybrids: Synthesis and Antimicrobial Action.

Authors:  Dina Ahmed Mosselhy; Yanling Ge; Michael Gasik; Katrina Nordström; Olli Natri; Simo-Pekka Hannula
Journal:  Materials (Basel)       Date:  2016-03-05       Impact factor: 3.623

6.  Silica-gentamicin nanohybrids: combating antibiotic resistance, bacterial biofilms, and in vivo toxicity.

Authors:  Dina A Mosselhy; Wei He; Ulla Hynönen; Yaping Meng; Pezhman Mohammadi; Airi Palva; Qingling Feng; Simo-Pekka Hannula; Katrina Nordström; Markus B Linder
Journal:  Int J Nanomedicine       Date:  2018-11-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.